U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse announces the availability of funding for implementation of the Exploratory Studies of Smoking Cessation Interventions for People With Schizophrenia (R21/R33) Grant. The purpose of this grant is to generate and conduct preliminary tests of targeted smoking cessation treatments for individuals with schizophrenia. Smokers with schizophrenia who have co-occurring alcohol and/or substance abuse disorders are also a population of interest. Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each Institute's grants management contact for . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | May 19, 2014

Federal Government Announces Exploratory Studies of Smoking Cessation Interventions for People With Schizophrenia (R21/R33) Grant Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member